Passage Bio Inc. (NASDAQ: PASG) Stock Information | RedChip

Passage Bio Inc. (NASDAQ: PASG)


$0.8171
-0.0119 ( -0.23% ) 263.5K

Passage Bio Inc is a genetic medicines company. The company is focused on developing transformative therapies for rare, monogenic CNS disorders. It has pipeline products such as GM1 Gangliosidosis, Frontotemporal dementia, and Krabbe Disease.

Market Data


Open


$0.8171

Previous close


$0.8290

Volume


263.5K

Market cap


$46.94M

Day range


$0.7660 - $0.8730

52 week range


$0.4510 - $1.7900

SEC Filings


Form Type Description Pages Date
4 Insider transactions 1 Oct 02, 2024
4 Insider transactions 1 Sep 23, 2024
4 Insider transactions 1 Sep 18, 2024
8-k 8K-related 47 Sep 16, 2024
8-k 8K-related 13 Sep 10, 2024
8-k 8K-related 13 Sep 06, 2024
3 Insider transactions 1 Aug 09, 2024
10-q Quarterly Reports 64 Aug 08, 2024
8-k 8K-related 45 Aug 08, 2024
8-k 8K-related 13 Aug 02, 2024

Latest News